109146 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A. MicroRNAs, miRNAs
Mir-17˜92 as therapeutic or diagnostic target of motor neuron (MN) degeneration diseases
#902Targeted delivery of therapeutic agents to human adipocytes
#903Treatment of angiogenesis disorders
#904PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#905Ocular applications of matrix bound vesicles (MBVs)
#906COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEAR-PENETRATING ANTIBODIES
#907COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#908Method for reducing the expression of NKCC1 in a subject
#909CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR OR ENGINEERED TCR AND COMPRISING A NUCLEOTIDE SEQUENCE WHICH IS SELECTIVELY EXPRESSED
#910Inhibitors of metastasis
#911EXOSOMES DERIVED FROM CORTICAL BONE STEM CELLS CAN AUGMENT HEART FUNCTION AFTER CARDIAC INJURY
#912METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASE OR DISORDER
#913Methods of producing cells resistant to HIV infection
#914Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#915Composition for delivering nucleic acid and nucleic acid-containing composition
#916Methods for modulating regulatory T cells, regulatory b cells, and immune responses using modulators of the april-taci interaction
#917MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#918Cationic polymers
#919MicroRNA Compounds and Methods for Modulating MIR-122
#920APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF
#921Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128
#922DESIGNING SENSITIVE, SPECIFIC, AND OPTIMALLY ACTIVE BINDING MOLECULES FOR DIAGNOSTICS AND THERAPEUTICS
#923Use of MIR101 or MIR128 in the treatment of seizure disorders
#924MicroRNA-based logic gates and uses thereof
#925Trans-activated functional RNA by strand displacement and uses thereof
#926Methods for treating brain injury
#927Micro RNA expression constructs and uses thereof
#928TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma
#929Methods and compositions for treating inflammatory diseases
#930OLIGODENDROCYTE-SPECIFIC PROMOTER, MIRNA SPECIFIC TO PLP1 GENE,VECTOR INCLUDING SAID PROMOTER AND/OR MIRNA, AND PHARMACEUTICAL COMPOSITION INCLUDING SAID VECTOR
#931Edible plant-derived nanoparticles for regulation of gut microbiota
#932METHODS FOR THE TREATMENT OF PROSTATE CANCER
#933COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION
#934MICRORNA 584-5P COMPOSITIONS AND METHODS FOR TREATING CANCER
#935MicroRNA hsa-miR-665 in cardiac hypertrophy
#936RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION
#937Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer
#938CITRUS GREENING (HUANGLONGBING-INDUCED SMALL RNAS ARE POTENTIAL EARLY DIAGNOSIS MARKERS
#939Plant sRNA extract or plant miRNA for use as an immunosuppressive agent
#940Cancer stem cell growth inhibitor using miRNA
#941Liposomal particles, methods of making same and uses thereof
#942Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#943Lipid-derived neutral nanoparticles
#944MicroRNA-based compositions and methods used in disease treatment
#945Double-helix oligonucleotide construct comprising double-stranded miRNA and use thereof
#946Peptides and nanoparticles for intracellular delivery of molecules
#947Nucleic acid complex, method for forming nucleic acid hybridization, pharmaceutical composition, nucleic acid probe, and complementary-strand nucleic acid complex
#948Compact gyroplane employing torque compensated main rotor and hybrid power train
#949Topical silk compositions and methods of using
#950METHODS AND COMPOSITIONS RELATED TO INCREASED ROTAVIRUS PRODUCTION
#951Gene therapeutics for treating bone disorders
#952MLK-regulated microRNAs in angiogenesis and tumor development
#953In vitro and in vivo intracellular delivery of siRNA via self-assembled nanopieces
#954Preparation and use of nanoparticle-doped RNA hydrogel targeting to triple negative breast cancer
#955Inhibitors of micro-RNA 22
#956Micro-RNA and obesity
#957Compositions and methods for cellular reprogramming
#958METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES
#959Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid
#960Gene therapies for lysosomal disorders
#961REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#962Immunotherapeutic constructs and methods of their use
#963COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#964Stem cell-derived exosomes for the treatment of corneal scarring
#965USING INFECTIOUS NUCLEIC ACID TO TREAT CANCER
#966HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA
#967MODELING TDP-43 PROTEINOPATHY
#968Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure
#969MATERIALS AND METHODS FOR PREVENTING TRANSMISSION OF A PARTICULAR CHROMOSOME
#970Loss of function alleles of PtEPSP-TF and its regulatory targets in rice
#971Method for diagnosis of Alzheimer's disease using microRNA
#972Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages
#973COMPOSITIONS COMPRISING CURONS AND USES THEREOF
#974METHODS OF MODULATING ALK
#975Micro-RNA profiling, compositions, and methods of treating diseases
#976Compositions and methods for treatment of cardiac diseases
#977Gene editing for hemophilia A with improved factor VIII expression
#978HIV IMMUNOTHERAPY WITH NO PRE-IMMUNIZATION STEP
#979METHODS AND COMPOSITIONS FOR GENERATING DOMINANT ALLELES USING GENOME EDITING
#980COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE
#981COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF
#982GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS
#983NONTOXIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF HERPESVIRUS INFECTIONS
#984SHIP INHIBITION TO COMBAT OBESITY
#985METHOD TO IDENTIFY AND VALIDATE GENOMIC SAFE HARBOR SITES FOR TARGETED GENOME ENGINEERING
#986Compositions and methods to treating hemoglobinopathies
#987Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics
#988Engineered post-poly A signal RNA and uses thereof
#989Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products
#990METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
#991Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
#992Method for inhibiting the expression of cancer-promoting factors
#9935-halouracil-modified microRNAs and their use in the treatment of cancer
#994FMRP and cancer treatment
#995MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
#996GUIDED MAGNETIC NANOSTRUCTURES FOR TARGETED AND HIGH-THROUGHPUT INTRACELLULAR DELIVERY
#997TRANSGENIC PLANT OF THE SPECIES SOLANUM TUBEROSUM WITH RESISTANCE TO PHYTOPHTHORA
#998Method for promoting an increase in plant biomass, productivity, and drought resistance
#999Method for producing exosomes and exosomes obtained thereby
#1000Direct reprogramming of cells to cardiac myocyte fate
#1001METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSE ASSOCIATED WITH AAV TRANSDUCTION
#1002RNAi induced huntingtin gene suppression
#1003RAAV-based compositions and methods
#1004Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA
#1005Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
#1006Adeno-associated virus virion for gene transfer to nervous system cells
#1007VECTORS CONTAINING AIMP2-DX2 AND TARGET NUCLEIC ACIDS FOR miR 142 AND USES THEREOF
#1008MicroRNA-294 and Lin28A as a driver of cardiac tissue proliferation in response to pathological injury
#1009Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#1010Gene therapy for neurodegenerative disorders
#1011POLYNUCLEOTIDE CONJUGATES AND USES THEREOF
#1012Methods for Resensitizing p53-Null Cells to Cancer Chemotherapy
#1013METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#1014miR-133a as a marker for colorectal cancer
#1015Preeclampsia
#1016Delivery method of target material into extracellular vesicles using extracorporeal shockwave
#1017Exosomal loading using hydrophobically modified oligonucleotides
#1018Composition for preventing or treating liver fibrosis, containing exosome or exosome-derived ribonucleic acid
#1019Use of miR-18b for prevention, treatment, or diagnosis of muscle disease and neuromuscular disease
#1020Combination immunotherapies for treatment of cancer
#1021USE OF MEDEA ELEMENTS FOR BIOCONTROL OF D. SUZUKII POPULATIONS
#1022Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
#1023Cancer-specific trans-splicing ribozymes and use thereof
#1024MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION IN EUKARYOTIC CELLS
#1025USE OF ANTI-CRISPR POLYPEPTIDES FOR SPECIFIC ACTIVATION OF CAS NUCLEASES
#1026Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#1027Glaucoma treatment
#1028Genomic insulator elements and uses thereof
#1029Compositions and methods for treating hepatic fibrosis
#1030Compositions and processes for targeted delivery, expression and modulation of coding ribonucleic acids in tissue
#1031Method for treating a neurological disorder comprising administering ASM inhibitors
#1032COMPOSITIONS AND METHODS FOR REGULATION OF GENE EXPRESSION WITH, AND DETECTION OF, FOLINIC ACID AND FOLATES
#1033miRNA biogenesis in exosomes for diagnosis and therapy
#1034Virus for treatment of tumor
#1035Therapeutic pharmaceutical composition for cancer including miRNA
#1036Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
#1037Methods for extracting bioactive small RNAs from plants and mushrooms
#1038METHODS OF TREATING MOTOR NEURON DISEASES
#1039Bioinformatics methods of in silico validation and selection of circRNAs
#1040Nanoparticle conjugates and uses thereof
#1041Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#1042Gene therapies for lysosomal disorders
#1043Gene therapies for lysosomal disorders
#1044Genetically engineered coxsackievirus, and pharmaceutical composition
#1045Biodegradable lipids for delivery of nucleic acids
#1046Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia
#1047Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke
#1048Platelets as delivery agents
#1049Compositions and methods for delivery of agents
#1050COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO
#1051Methods and compositions for screening and treating developmental disorders
#1052RECOMBINANT ONCOLYTIC VIRUS
#1053Viral vector production
#1054Inducible expression of genes in algae
#1055Modulatory polynucleotides
#1056ROLE OF EXOSOMES, EXTRACELLULAR VESICLES, IN THE REGULATION OF METABOLIC HOMEOSTASIS
#1057EXTRACELLULAR VESICLES FOR AGENT DELIVERY
#1058Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling
#1059PKLR inhibition in the treatment of NAFLD and HCC
#1060MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#1061Anellovirus compositions and methods of use
#1062Compositions and methods for the treatment of fibrotic diseases
#1063Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
#1064METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES
#1065MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS
#1066Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome
#1067Double-stranded oligo RNA structure comprising miRNA
#1068Compositions and methods for detecting and treating insulin resistance
#1069COMPOSITIONS COMPRISING APTAMERS AND NUCLEIC ACID PAYLOADS AND METHODS OF USING THE SAME
#1070Cancer Treatment Based on Delivery of Oligoes via Gap Junctions from Human Mesenchymal Stem Cells (hMSC)
#1071Compositions for the treatment of disease
#1072METHODS OF IDENTIFYING MIRNAS AND APPLICATIONS THEREOF
#1073INHIBITION OF VASCULAR ENDOTHELIAL CELL-MEDIATED PHAGOCYTIC PROCESSES FOR TREATMENT OF DEMYELINATING CONDITIONS
#1074COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER
#1075Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#1076Compositions and methods of treating Huntington's disease
#1077Modulatory polynucleotides
#1078MODULATING BIOMARKERS TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY
#1079Oncolytic viral vectors and uses thereof
#1080COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS
#1081Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
#1082Nucleoporins as drug targets for anti-proliferative therapeutics
#1083COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCER
#1084Myostatin iRNA compositions and methods of use thereof
#1085Detection and treatment of neurological diseases
#1086A TRANSGENIC PLANT HAVING RESISTANCE TO A PHYTO-PATHOGENIC FUNGUS
#1087SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT
#1088ANTI-REFLECTIVE ARTICLES WITH NANOSILICA-BASED COATINGS
#1089COMPOSITIONS COMPRISING CURONS AND USES THEREOF
#1090PH-sensitive lipid nanoparticles for encapsulation of anticancer drugs and microRNA and use thereof
#1091Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
#1092HIV pre-immunization and immunotherapy
#1093Gemcitabine Derivatives for Cancer Therapy
#1094Beta-TUBULIN, Beta-TUBULIN GENE AND APPLICATION OF GENE SEGMENT THEREOF
#1095Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain
#1096Transkingdom platform for therapeutic nucleic acid delivery
#1097DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS
#1098Adoptive cell therapy using spherical nucleic acids (SNAs)
#1099COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#1100FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF
#1101AAV treatment of Huntington's disease
#1102CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES
#1103NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS
#1104Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules
#1105Gene therapies for lysosomal disorders
#1106COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS DRUGS FOR TREATING ALZHEIMER'S DISEASES
#1107TREATMENT OF ALZHEIMERS DISEASE WITH MICRO RNA AND GHRELIN
#1108MicroRNA inhibitor
#1109Compositions of asymmetric interfering RNA and uses thereof
#1110MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#1111Methods and compositions for the activation of gamma-delta T-cells
#1112Inhibitors of CACNA1A/ALPHA1A subunit internal ribosomal entry site (IRES) and methods of treating spinocerebellar ataxia type 6
#1113Riboswitch modulated gene therapy for retinal diseases
#1114METHODS, SYSTEMS, AND COMPOSITIONS FOR NEURONAL DIFFERENTIATION OF MULTIPOTENT STROMAL CELLS
#1115Regulation of MIR-143 using nucleic acid molecules
#1116Compositions of asymmetric interfering RNA and uses thereof
#1117Application of Imidazopyridine Derivatives in Regenerative Medicine
#1118Amine-containing transfection reagents and methods for making and using same
#1119Compositions for facilitating membrane fusion and uses thereof
#1120Methods for detection of RNase activity
#1121Treatment of tumors with miRNA targeting CDK4/CDK6
#1122Compositions comprising bacterially derived minicells and methods of using the same
#1123Methods to detect motor neuron disease comprising micro-RNAs
#1124Novel Structurally Designed shRNAs
#1125Electroporation, developmentally-activated cells, pluripotent-like cells, cell reprogramming and regenerative medicine
#1126Gene therapy for retinitis pigmentosa
#1127Diagnosis and treatment of psoriatic arthritis
#1128RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1129Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1130Lin28-mediated control of let-7 biogenesis
#1131Recombinant AAV variants and uses thereof
#1132Exosomes and micro-ribonucleic acids for tissue regeneration
#1133Liposomal particles, methods of making same and uses thereof
#1134Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#1135Human neural precursor cells with inducible STIM1 knockdown
#1136Methods for identifying treatment targets based on multiomics data
#1137Biodegradable compound, lipid particles, composition and kit comprising lipid particles
#1138High cAMP yielding yeast strain and use thereof
#1139STEM CELL MICROPARTICLES
#1140Prognostic methods and systems of treatment for acute lymphoblastic leukemia
#1141Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor
#1142K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereof
#1143Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
#1144STEM CELL MICROPARTICLES AND miRNA
#1145Transgenic plants with enhanced traits
#1146COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA
#1147Method for assaying MicroRNA, cancer therapeutic agent, and medical composition containing same for cancer therapy
#1148Gene vector
#1149RECOMBINANT BACULOVIRUSES AND USES THEREOF
#1150BIOLOGICAL CONTROLS OF COLEOPTERAN PESTS
#1151Treatment of angiogenesis disorders
#1152Exosome delivery system
#1153Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
#1154RNAI THERAPIES FOR CEREBRAL ISCHEMIA
#1155Compositions and methods used in diagnosing and treating colorectal cancer
#1156Endosomal cleavable linkers
#1157Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
#1158Inducer of muscle differentiation
#1159Consequences of a defective switch in cutaneous squamous cell carcinoma
#1160METHODS FOR ENHANCING VASCULAR DENSITY
#1161Method of treating diabetic retinopathy or wet type adult macular degeneration
#1162Compositions and methods to treating hemoglobinopathies
#1163RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1164REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOF
#1165Process of delivering small RNAs to sperm
#1166Compounds and methods for enhanced cellular uptake
#1167Compositions and methods for reducing neointima formation
#1168Compositions and methods for treating cancer
#1169MicroRNA in T cell activation
#1170Recombinant virus products and methods for inhibition of expression of DUX4
#1171METHODS OF TREATING NEUROBLASTOMA AND REAGENTS THEREFOR
#1172METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
#1173Combination immunotherapies for treatment of cancer
#1174Compositions for transfecting resistant cell types
#1175POLY(ETHYLENE GLYCOL) BRUSHES FOR EFFICIENT RNA DELIVERY
#1176COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#1177Method for modifying genes
#1178Plasmid vector for expressing a PVT1 exon and method for constructing standard curve therefor
#1179MicroRNAs and methods of their use
#1180Isolation of novel AAV's and uses thereof
#1181CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1182CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1183CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#1184LUNG CANCER DIAGNOSTICS AND THERAPEUTICS WITH MIR-660
#1185RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1186Crosslinked micellar spherical nucleic acids
#1187Microrna let-7 and transforming growth factor beta receptor III axis as target for cardiac injuries
#1188Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
#1189Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
#1190Non-integrating viral delivery system and methods related thereto
#1191Inhibiting microRNA to prevent development of essential hypertension
#1192MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
#1193Cancer-treating pharmaceutical composition inhibiting expression of CCND3 or PAK2 gene
#1194MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#1195Compositions and methods for treatment of cardiac diseases
#1196Recombinant virus products and methods for inhibition of expression of myotilin
#1197Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1198Nontoxic compounds for the treatment and prevention of herpesvirus infections
#1199Therapeutic Compositions Comprising Mesenchymal Stem Cell Particles And Related Methods
#1200SPATIOTEMPORAL REGULATORS